Prognosis ‘poor’ in hepatic encephalopathy despite rifaximin therapy
Australian researchers emphasise the need to consider liver transplant in these patients
UPDATED: 11 June
Patients with liver cirrhosis who are admitted for hepatic encephalopathy fare poorly, with the majority dying within a year, Australian researchers say.
